欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/0523/004
药品名称	Olmetec Plus 40 mg/25 mg Filmtabletten
活性成分	hydrochlorothiazide 25.0 mg olmesartan medoxomil 40.0 mg
剂型	Film-coated tablet
上市许可持有人	Daiichi Sankyo Europe GmbH Zielstattstr. 48 81379 München Germany
参考成员国 - 产品名称	Germany (DE)
互认成员国 - 产品名称	Belgium (BE) Netherlands (NL) Luxembourg (LU) United Kingdom (Northern Ireland) (XI) France (FR) Spain (ES) Portugal (PT) Greece (GR) Italy (IT)
许可日期	2009/12/21
最近更新日期	2023/12/01
药物ATC编码	C09DA08 olmesartan medoxomil and diuretics
申请类型	TypeLevel1：Line Extension TypeLevel2：Additional Strength/Form TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	PAR \| DE_H_0523_0525_DC Olmesartan Daiichi_ final_PARDate of last change:2018/02/21 Final SPC \| common-spc-olmp20-cleanDate of last change:2017/03/17 Final PL \| common-pl-olmp20-cleanDate of last change:2017/03/17 Final SPC \| common-spc-olmp40-highlightedDate of last change:2017/03/17 Final SPC \| common-spc-olmp20-highlightedDate of last change:2017/03/17 Final SPC \| common-spc-olmp40-cleanDate of last change:2017/03/17 Final PL \| common-pl-olmp40-cleanDate of last change:2017/03/17 Final PL \| common-pl-olmp40-highlightedDate of last change:2017/03/17 Final PL \| common-pl-olmp20-highlightedDate of last change:2017/03/17 Final Labelling \| common-outer-olmp40Date of last change:2017/03/17 Final Labelling \| common-outer-olmp20Date of last change:2017/03/17 Final Labelling \| common-outer-olmp20-highlightedDate of last change:2017/03/17 Final Labelling \| common-outer-olmp40-highlightedDate of last change:2017/03/17
市场状态	Positive